Caparica R - Search Results

1

BRAF mutations in non-small cell lung cancer: has finally Janus opened the door?

Caparica R, de Castro G Jr, Gil-Bazo I, Caglevic C, Calogero R, Giallombardo M, Santos ES, Raez LE, Rolfo C. Caparica R, et al. Crit Rev Oncol Hematol. 2016 May;101:32-9. doi: 10.1016/j.critrevonc.2016.02.012. Epub 2016 Feb 27. Crit Rev Oncol Hematol. 2016. PMID: 26960735 Review.

2

The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer.

Passiglia F, Caparica R, Giovannetti E, Giallombardo M, Listi A, Diana P, Cirrincione G, Caglevic C, Raez LE, Russo A, Rolfo C. Passiglia F, et al. Among authors: caparica r. Expert Opin Investig Drugs. 2016;25(4):385-92. doi: 10.1517/13543784.2016.1152261. Epub 2016 Feb 24. Expert Opin Investig Drugs. 2016. PMID: 26881293 Review.

3

B-RAF mutation in non-small cell lung cancer: the sleeping beauty is waking up.

Rolfo C, Caparica R. Rolfo C, et al. Among authors: caparica r. Transl Lung Cancer Res. 2016 Aug;5(4):367-9. doi: 10.21037/tlcr.2016.07.04. Transl Lung Cancer Res. 2016. PMID: 27650165 Free PMC article. No abstract available.

4

Responses to Crizotinib Can Occur in High-Level MET-Amplified Non-Small Cell Lung Cancer Independent of MET Exon 14 Alterations.

Caparica R, Yen CT, Coudry R, Ou SI, Varella-Garcia M, Camidge DR, de Castro G Jr. Caparica R, et al. J Thorac Oncol. 2017 Jan;12(1):141-144. doi: 10.1016/j.jtho.2016.09.116. Epub 2016 Sep 21. J Thorac Oncol. 2017. PMID: 27664533 Free article.

5

Effectiveness and toxicity of adjuvant chemotherapy in patients with non-small cell lung cancer.

Harada G, Neffa MFBV, Bonadio RC, Mendoza EZ, Caparica R, Lauricella LL, Takagaki TY, Roitberg FSR, Terra RM, Castro G Jr. Harada G, et al. Among authors: caparica r. J Bras Pneumol. 2021 Feb 24;47(3):e20200378. doi: 10.36416/1806-3756/e20200378. eCollection 2021. J Bras Pneumol. 2021. PMID: 33656100 Free PMC article.

6

Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial.

Tan DSW, Felip E, de Castro G, Solomon BJ, Greystoke A, Cho BC, Cobo M, Kim TM, Ganguly S, Carcereny E, Paz-Ares L, Bennouna J, Garassino MC, Schenker M, Kim SW, Brase JC, Bury-Maynard D, Passos VQ, Deudon S, Dharan B, Song Y, Caparica R, Johnson BE. Tan DSW, et al. Among authors: caparica r. J Clin Oncol. 2024 Jan 10;42(2):192-204. doi: 10.1200/JCO.23.00980. Epub 2023 Dec 1. J Clin Oncol. 2024. PMID: 38039427 Clinical Trial.

7

Adjuvant chemotherapy in biliary tract cancer patients: A systematic review and meta-analysis of randomized controlled trials.

Caparica R, Bruzzone M, Hachem GE, Ceppi M, Lambertini M, Glasberg J, de Azambuja E, Van Laethem JL, Hendlisz A. Caparica R, et al. Crit Rev Oncol Hematol. 2020 May;149:102940. doi: 10.1016/j.critrevonc.2020.102940. Epub 2020 Mar 19. Crit Rev Oncol Hematol. 2020. PMID: 32252001

8

Pulmonary Nodules in Patients With Nonpulmonary Cancer: Not Always Metastases.

Caparica R, Mak MP, Rocha CH, Velho PHI, Viana P, Moura MRL, Menezes MR, Amato MBP, Feher O. Caparica R, et al. J Glob Oncol. 2016 Feb 3;2(3):138-144. doi: 10.1200/JGO.2015.002089. eCollection 2016 Jun. J Glob Oncol. 2016. PMID: 28717693 Free PMC article.

9

Biomarkers of response and resistance to PI3K inhibitors in estrogen receptor-positive breast cancer patients and combination therapies involving PI3K inhibitors.

Brandão M, Caparica R, Eiger D, de Azambuja E. Brandão M, et al. Among authors: caparica r. Ann Oncol. 2019 Dec 1;30(Suppl_10):x27-x42. doi: 10.1093/annonc/mdz280. Ann Oncol. 2019. PMID: 31859350 Free PMC article. Review.

10

[No title available]

[No authors listed] [No authors listed] PMID: 31928692

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page